European Biotechnology News Science & Industry
May 2014
PREVI EW
May '14
II Cell-based Assays
SPECIAL
SPECIAL Special: Cell-based assays Benefit from an upswing market! ➤
Publication date: May 15th, 2014
Top coverage of all the relevant topics Physiologically relevant cellular assays are increasingly used to test drug candidates or decipher complex signaling pathways. One major development in recent years has been the implementation of these assays in highthroughput systems. 3D cell-based screenings are also gaining momentum, since cells thrive better in a threedimensional microenvironment than in two-dimensional settings. Developers in biopharma in particular have discovered the advantages of cell-based assays for testing the cytotoxicity and potency of their prospects. The future in the field looks bright. Analysts have forecast sales of over US$3bn in 2018 for the market that includes cell-based assays, cell lines, related equipment and software. To meet those high hopes, the five-year academicindustry partnership StemBANCC is aiming to provide well-characterised, patient-derived induced pluripotent stem cell lines and associated biomaterials in an accessible and sustainable biobank. In this issue, suppliers and vendors of cellular assays and cell-assay equipment have the opportunity to present their products and services to a handpicked audience, from labs in science to CSOs in the European biotech industry.
Selling your product or service! EuroBiotechNews offers a unique format for presenting your products and services to top-rung players throughout the European life sciences sector. This special provides the latest insights from the relevant experts, and is tailored to attract the interest of decisionmakers in research institutes and in the diagnostics, nutrition, chemicals and pharma sectors. It’s the perfect opportunity to target your specific audience and really get your message across!
Editorial Deadline 28-4-2014 Editorial Contact: Dr. Martin Laqua Tel: +49-30-264921-68 Fax: +49-30-264921-11 m.laqua@biocom.de
Booking 30-04-2014 Marketing Contact: Oliver Schnell Tel: +49-30-264921-45 Fax: +49-30-264921-11 o.schnell@biocom.de
BIOCOM AG | Luetzowstr. 33-36 | D-10785 Berlin | www.biocom.de
Publication 15-05-2014 Marketing Contact: Christian Boehm Tel: +49-30-264921-49 Fax: +49-30-264921-11 c.boehm@biocom.de
Cell-based Assays Special Edition: Meet your audience! European Biotechnology News is published in co-operation with the following organisations: European Biotechnology Net work
Europe: european-biotechnology.net
Germany: biodeutschland.org
Switzerland: swissbiotech.org
CMYK
CouncilBlue: of European 100/15/0/35 BioRegions Orange: 0/75/90/0
Belgium: edma-ivd.eu
Europe: cebr.net
Europe: eapb.org
Europe: europabio.org
Europe: ebe-biopharma.org
Ireland: ibec.ie/ibia
Norway: biotekforum.no
Denmark: danskbiotek.dk
Finland: finbio.net
The Netherlands: niaba.nl
Sweden: swedenbio.com
Spain: asebio.com
France: france-biotech.org
Hungary: hungarianbiotech.org
Belgium: bio.be
EuroBiotechNews covers the biotechnology sector of the current 28 EU member states, Norway and Switzerland. If you would like to subscribe, please refer to Portugal: www.apbio.pt
Italy: assobiotec.it
www.eurobiotechnews.eu
Media Info 2014 Nº 3 | Volume 12 | 2013 | 10.00 € | ISSN 1618-8276 | A 60711 |
European Biotechnology News Science & Industry
The English-language European Biotechnology News reports monthly on all of the latest political, economic and technical developments in the life sciences sector in all 28 EU countries plus Switzerland and Norway. With print runs of more than 15,000 copies per issue, this magazine provides the perfect platform for pan-European marketing campaigns seeking to profit from the advantages of a huge unified economic region.
ceNTRal eUROpe
Roche given green light for breast-cancer antibody drug
Subscription prices 2013: Annual subscription companies/individuals Annual subscription students/unemployed
NORTHeRN eUROpe
Scandinavian research alliance screens for novel antibiotics Special
€ 100 € 50
European n a e p o r Eu iotechnoloNgeyws B y g BiotecEhunroolpoNeeawns lpoegayn o n h c e t o i B Antibiotics Euro News from the ocean floor BiotecEhunroolpoNegeaywns BiotechnoloNgeyws Europegayn lo EuropeanBiotechno News BiotecEhunroolopegayn News ecEhunroolpoegaywns t o i B European Biotechnology News Dates Ngey Biocapital o l II European o n BioptiteaclEhuropNeeSupplement awns Issue Special Topics und EventHighlights Booking Publication a c io B y g o l II European cEhunroopeans Euro BioFairs Compass Spring/Summer Biote 1/2 31.01.14 13.02.14 eyw N BIO-Europe Spring 2014, Turin (IT)a n B io c a p it a l e p ro g u II E chnolo s e t o i B 3 Analytica 2014, Munich (GER) 28.02.14 13.03.14 NewS P E C I A L pital pean Bioca Intellectual Property in the life sciences industry
Subscription prices incl. VAT and delivery (valid for Germany).
WeSTeRN eUROpe
Irish Public-Private Partnership ploughs D300m into research
try
Science & Indus
Mediapartners (excerpt) Analytica, BIO-Europe, BioJapan Expo, BIO tech Japan, BioSpain, CPhI Worldwide, ScanBalt Forum
Published: dustry monthly, with two SOUTHeRN eUROpe Science & In Chiesi Farmaceutici set to take double-issues per year Octo ber 2012
over Cornerstone Therapeutics
2 Oct obe r 201
eaSTeRN eUROpe
stry Science & Indu Volume: Volume 13, 2014
Gedeon Richter forms joint venture with China’s Rxmidas
2 Oct obe r 201
Cooperation Partners (excerpt) EAPB, EDMA, EuropaBio, European Biotechnology Network l a it p ca Bio II European
stry
Science & Indu
ScieNce & TecHNOlOgy
Swiss researchers map allosteric interactions of bacterial proteins
2 Oct obe r 201
stry
Science & Indu
2 Oct obe r 201
Science &
y
3 Aug ust 201
stry
Science & Indu
2 Oct obe r 201
II Euro
Co m p BioFairs April 2013
SPECIAL
stry
Science & Indu
d 1
airs Euro BioFas Coomp s
Th erapies II Genomic stic nonostsics agag d Di & Di an
September 2012
II Euro
4
SPECIA
2 Oct obe r 201
Big Data, Intellectual Property Bio IT World, Boston (USA)
L
08.08.2013
SPECIAL
02.10.2012
l_pad.indd
18:16:56 Uhr
Uhr 15:00:53
28.03.14
27 tg.indd
t 2013_
pass_Herbs
_Titel_Com
13_SPECIAL
31_EBSIN8_
2_Special_Tite
35_EBSIN10_1
5
II Guide to Events Life Sciences
stry
Science & Indu
18:16:56 Uhr
Titel_pad.ind
_12_Special_
35_EBSIN10
2 Oct obe r 201
Science & Industr
ass
02.10.2012
stry Science & Indu
2 Oct obe r 201
Industry
SPECIAL
PECIAL
S 10.04.14 11.04.2013
11:06:00 Uhr
1
Biocapital n a e p ro u E II BIO 2014, San Diego (USA) Biocapital II European
Cell-based Assays
.indd 31
PECIAL_Titel_tg
31_EBN_4_13-S
SPECIAL
18:16:56 Uhr
30.04.14
15.05.14
SPECIAL
18:16:56 Uhr
28.05.14
12.06.14
18:16:56 Uhr
04.07.14
17.07.14
29.08.14
11.09.14
26.09.14
09.10.14
02.10.2012
d 1 _Titel_pad.ind
2_Special
35_EBSIN10_1
6
l_pad.indd
2_Special_Tite
35_EBSIN10_1
7/8
1
Biocapital n a e p ro u E II Biomanufacturing, CMO´s & CRO´s CPhI Worldwide 2014, Paris (F)p e a n B io c a p it a l II Euro d 1 _Titel_pad.ind
2_Special
10
airs Euro BioFas Coomp s
Euro BioFairs Compass Autumn/Winter 35_EBSIN10_1
9
02.10.2012
BIO-Europe 2014, Frankfurt/Main (GER)
02.10.2012
September 2012
II Guide to Events Life Sciences
SPECIAL SPECIAL
18:16:56 Uhr
SPECIAL
18:16:56 Uhr
07.11.14
20.11.14
SPECIAL
18:16:56 Uhr
05.12.14
18.12.14
02.10.2012
SPECIAL
1 l_pad.indd
2_Special_Tite
35_EBSIN10_1
11
Biobased Production, EFIB 2014
02.10.2012
d 1
l_pad.ind 2_Special_Tite
35_EBSIN10_1
12
Best Innovations, Products, Technologies in 2014
02.10.2012
1 l_pad.indd
2_Special_Tite
35_EBSIN10_1
Editorial deadline for each individual issue is two workdays ahead of the booking deadline. l_pad.indd
2_Special_Tite
35_EBSIN10_1
1
02.10.2012
18:16:56 Uhr
Advertising rates: 1/1 page (4c) 1/2 page (4c) 1/3 page (4c) 1/4 page (4c) 1/8 page (4c)
>15,000
copies per month!
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
€ 3,600 € 2,400 € 1,950 € 1,650 € 1,350
Product information . . . . . . . . . . . . .
€ 400
(by arrangement)
Company profile:
In cooperation
20
with European biotechassociations!
1/1 page Advertorial/Company profile (4,000 characters + 1 image) . . . . . . . . 2/1 page Advertorial/Company profile (8,000 characters + 2 images) . . . . . . .
€2,500 €4,000
Job: 1/1 page b/w . . . . . . . . . . . . . . . . 1/2 page b/w . . . . . . . . . . . . . . . . 1/4 page b/w . . . . . . . . . . . . . . . .
€1,000 €500 €250
Special placement addition (e.g. cover pages) . . . . . .
€500
Inserts: 2-page . . . . . . . . . . . . . . . . . Prices on request 4-page . . . . . . . . . . . . . . . . . . . €4,000
Perfect for advertising campaigns across Europe!
Supplements: Up to 25 g . . . . . . . . . . . . . . . . . . Up to 50 g . . . . . . . . . . . . . . . . . .
€3,000 €5,000
plus delivery charges
Geographic Coverage:
Recipients according to sector:
Region . . . . . . . . . . . . . . . . . . . . ����� Copies Western Europe (GB, IRL, F and BeNeLux,) 32 % 4,966 Central Europe (D, A and CH) . . . . . 25 % 3,880 Southern Europe (P, E, I, GR, M and CY) 13 % 2,018 Northern Europe (S, FIN, DK and NOR) . 11 % 1,708 Eastern Europe (PL, CZ, SK, HR, HUN, SLO, LIT, LET and EST) . . . . . . . . . . . . . 11 % 1,707 Other regions (USA, CDN, J and IND) . . . . . . . . . . . . . . . . . 8 % 1,241
INDUSTRY . . . . . . . . . . . . . . . . . Companies pharma / medicine / biotechnology . . . . . . . . . . . . . . . . Industrial large-scale production / chemistry . Service provider / supplier / laboratory . . . . Agriculture and food production . . . . . . .
81 %
RESEARCH . . . . . . . . . . . . . . . . . Public-law research institutes . . . . . . . . . Private industry research institutes . . . . . .
18 % 10 % 8 %
Circulation:
PRIVATE PERSONS / OTHER . . . . . . . . Total print . . . . . . . . . . . . . . . . . . Actually circulated copies . . . . . . . . . . . Regular recipients / subscribers . . . . . . . . I received as part of membership package . . I as single subscriptions . . . . . . . . . . . Complimentary copies . . . . . . . . . . . . I of which delivered to trade fairs, congresses, cooperating companies / institutions . . . . Archive and author copies . . . . . . . . . .
16,000 15,520 10,270 7,610 2,660 5,250
2,810 480
34 % 21 % 18 % 8 %
1 %
Recipients according to position: I Lab- / division- / unit-leaders . . . . . . . . I Company / operating management . . . . . I Politics / foreign trade / business development I Research / development / education . . . . I Distribution / sales / marketing . . . . . . . I Organisation / administration / personnel . . I Private subscribers / other . . . . . . . . . .
25 % 16 % 15 % 15 % 11 % 10 % 8 %
Contacts: Oliver Schnell, Andreas Macht, Christian Böhm | Tel. +49 030 264921-45/-54/-49 | eMail: marketing@biocom.de